The company delivered fourth quarter and full-year net sales growth in 2025, exceeding guidance. Latest quarterly revenue reached $1.28B with a 6.26% year-over-year increase and net profit up 52%. However, the company faces rising regulatory scrutiny and shifting consumer preferences that threaten growth, with flat volumes and maturing markets undermining expansion efforts.
Cyborg Score Rationale
Strong recent profitability recovery with net profit up 52% year-over-year, but regulatory headwinds and negative MLM perceptions create structural challenges to sustainable growth. Valuation appears attractive at current levels.
Top Insights
Cristiano Ronaldo invested $7.5M in Pro2col™ technology for 10% equity stake (February 2026)
Debt refinancing announced to optimize capital structure (February 2026)
Quarterly net profit surge of 52% demonstrates improved operational efficiency
Regulatory scrutiny on MLM business model and shifting consumer preferences present material downside risks
Named Competitors
Nutrition Supplements — Direct selling nutritional and skincare products
Nutrition & Wellness — Multi-level marketing nutrition and beauty brands
Nutrition Products — Organic and health-focused food products
Recent Developments
(February 2026) Announced refinancing of senior secured debt
(February 2026) Cristiano Ronaldo invests $7.5M in Pro2col™ technology, acquires 10% stake
(February 2026) Exceeded full-year 2025 guidance on net sales and adjusted EBITDA
(January 2026) Maxim Group initiates Buy coverage
Open the full interactive Herbalife Ltd. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.